Physician attitudes toward treatment options for cerebrovascular disease

L A Weisberg1

  • 1Department of Neurology and Psychiatry, Tulane Medical School, New Orleans, LA, U.S.A.

Insights

Younger physicians show more aggressive treatment preferences for cerebrovascular diseases like transient ischemic attacks (TIAs) and stroke compared to older physicians. This age-related difference impacts therapeutic choices for preventing cardiovascular and cerebrovascular events.

Area of Science:

  • Neurology
  • Cardiology
  • Medical Education
  • Geriatrics

Background:

  • Physician treatment preferences significantly influence patient outcomes in cerebrovascular and cardiovascular diseases.
  • Understanding age-related differences in physician attitudes is crucial for optimizing patient care strategies.
  • Existing research highlights varying approaches to managing cardiovascular conditions, but less is known about cerebrovascular disease management differences based on physician age.

Purpose of the Study:

  • To compare the treatment preferences of younger and older physicians for patients experiencing transient ischemic attacks (TIAs) or completed stroke.
  • To assess how these preferences align with established cardiovascular disease prevention strategies for angina pectoris and myocardial infarction.
  • To identify age-specific therapeutic nihilism or aggression in managing cerebrovascular versus cardiovascular conditions.

Main Methods:

  • Survey of 200 physicians (100 older than 50, 100 younger than 50) regarding treatment preferences.
  • Comparison of attitudes towards cerebrovascular disease (TIA, stroke) and cardiovascular disease (angina, myocardial infarction) management.
  • Analysis of specific treatment modalities, including ticlopidine and oral anticoagulants.

Main Results:

  • Physicians younger than 50 demonstrated therapeutically aggressive approaches for both cerebrovascular and cardiovascular diseases.
  • Physicians older than 50 were aggressive for cardiovascular disease but exhibited therapeutic nihilism towards cerebrovascular disease.
  • Younger physicians were more likely to favor aggressive treatment for TIAs compared to completed strokes and more frequently utilized ticlopidine and oral anticoagulants for both conditions.

Conclusions:

  • Significant age-related disparities exist in physician treatment preferences for cerebrovascular diseases.
  • Younger physicians adopt a more aggressive and evidence-based approach to managing TIAs and strokes, including the use of specific pharmacotherapies.
  • Targeted educational interventions may be necessary to address therapeutic nihilism among older physicians regarding cerebrovascular disease management.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
569
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
410
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
608
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
669